GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Promisia Healthcare Ltd (NZSE:PHL) » Definitions » Research & Development

Promisia Healthcare (NZSE:PHL) Research & Development : NZ$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 1983. Start your Free Trial

What is Promisia Healthcare Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Promisia Healthcare's Research & Development for the six months ended in Mar. 2024 was NZ$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.00 Mil.

Promisia Healthcare Research & Development Historical Data

The historical data trend for Promisia Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Promisia Healthcare Research & Development Chart

Promisia Healthcare Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 - - - -

Promisia Healthcare Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Oct20 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Promisia Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Promisia Healthcare  (NZSE:PHL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Promisia Healthcare Research & Development Related Terms

Thank you for viewing the detailed overview of Promisia Healthcare's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Promisia Healthcare (NZSE:PHL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Promisia Healthcare Ltd (NZSE:PHL) » Definitions » Research & Development
Comparable Companies
NZSE:TAH NZSE:RAD HCA SAU:4013 XTER:FRE SZSE:300015 THC BSP:RDOR3 BKK:BDMS XTER:FME DVA UHS XKLS:5225 ADX:PUREHEALTH HKSE:06618 NSE:APOLLOHOSP BOM:543220 EHC CHE ASX:RHC
Traded in Other Exchanges
N/A
Address
50 Customhouse Quay, Level 2, Wellington, NZL, 6011
Website
https://www.promisia.co.nz
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Rest Home Care; Hospital Care; Respite Care; Young Disabled Care; Dementia Care; Palliative Care; Adult Day Care and others. The Group operates in one operating segment the provision of aged care in New Zealand.

Promisia Healthcare (NZSE:PHL) Headlines

No Headlines